RXST
Rxsight Inc
NASDAQ: RXST · HEALTHCARE · MEDICAL DEVICES
$6.25
-0.64% today
Updated 2026-08-04
Market cap
$253.76M
P/E ratio
—
P/S ratio
1.99x
EPS (TTM)
$-1.15
Dividend yield
—
52W range
$4 – $13
Volume
1.2M
Rxsight Inc (RXST) Financial Forecast & Price Target 2030
Revenue-driven projection model with historical context.
Price target summary
Current price
$6.25
12-Month target
—
2030 Target
—
Intrinsic (DCF)
$27.94
Financial forecast
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | $0.0B | $0.0B | $0.1B | $0.1B | $0.1B |
| EPS | — | — | — | — | — |
CAGR applied: — (capped 20%) · P/E: 25.00x (capped 25x) · Margin: -36.60%
Methodology
CAGR-based projection model. Research-backed estimates are being generated — check back soon for analyst consensus and management guidance.